EXAS News and Press, Exact Sciences Corporation From 02/13/26

2026-02-13 18:00:09 ET Hungarian-American investor George Soros's Soros Fund increased its stake in Microsoft ( MSFT ), NVIDIA ( NVDA ), and Apple ( AAPL ) as part of its Q4 portfolio positioning changes.... Read the full article on Seek...

Fourth quarter and 2025 highlights Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Precision Oncology revenue of $183 million Total 2025 revenue of $3.25 billion, an increase of 18% on a ...

2026-02-12 12:38:00 ET The following segment was excerpted from the Alger Mid Cap 40 ETF Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Alger Mid Cap 40 ETF Q4 2025 Portfolio Update

2026-02-12 01:20:00 ET The following segment was excerpted from the Baron Opportunity Fund Q4 2025 Shareholder Letter. ... Read the full article on Seeking Alpha For further details see: Baron Opportunity Fund Q4 2025 Portfolio Activity

2026-02-10 06:49:00 ET A single M&A deal with a transaction value of more than $10 billion was announced in January, the lowest monthly large deal count since August 2024.... Read the full article on Seeking Alpha For further details see: Soft Start For $10B-Plus M&a...

2026-02-06 13:35:52 ET More on Exact Sciences, Abbott Laboratories Abbott: Long-Term Investment Opportunity For Dividend Growth Investors Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy Abbott Laboratories: The Market's Overreaction Is The Long-Term ...

Passage of MCED legislation marks major milestone for early cancer detection Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today celebrated the passage of landmark federal legislation that establishes a pathway to enable Medicare cov...

Milestone underscores test’s significant role as a global standard-of-care in guiding personalized breast cancer treatment The predictive utility of this test helped an estimated 1.6 million patients safely avoid potentially unnecessary chemotherapy Economic models demonstr...

2026-02-02 12:05:00 ET Shares of Abbott Laboratories (NYSE: ABT) recently plunged after the company announced its fourth-quarter results. Over the trailing 12 months, the stock is down 16%. Some might choose to stay away from Abbott given some recent challenges. However, Abbott's st...

2026-01-29 13:22:00 ET The following segment was excerpted from the Alger Small Cap Focus Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Alger Small Cap Focus Fund Q4 2025 Portfolio Update